95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.93%
Negative revenue growth while NEM stands at 11.26%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-17.34%
Negative gross profit growth while NEM is at 13.45%. Joel Greenblatt would examine cost competitiveness or demand decline.
-16.55%
Negative EBIT growth while NEM is at 8.64%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-16.55%
Negative operating income growth while NEM is at 8.64%. Joel Greenblatt would press for urgent turnaround measures.
-15.36%
Negative net income growth while NEM stands at 31.54%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.00%
Negative EPS growth while NEM is at 32.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.00%
Negative diluted EPS growth while NEM is at 32.14%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.05%
Share change of 0.05% while NEM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.12%
Diluted share count expanding well above NEM's 0.20%. Michael Burry would fear significant dilution to existing owners' stakes.
-44.44%
Dividend reduction while NEM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-25.60%
Negative OCF growth while NEM is at 65.42%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-394.81%
Negative FCF growth while NEM is at 54.77%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
474.43%
10Y revenue/share CAGR above 1.5x NEM's 175.57%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
155.90%
5Y revenue/share CAGR above 1.5x NEM's 37.30%. David Dodd would look for consistent product or market expansions fueling outperformance.
104.72%
3Y revenue/share CAGR above 1.5x NEM's 19.57%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
318.78%
10Y OCF/share CAGR above 1.5x NEM's 88.03%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
198.21%
Positive OCF/share growth while NEM is negative. John Neff might see a comparative advantage in operational cash viability.
151.07%
Positive 3Y OCF/share CAGR while NEM is negative. John Neff might see a big short-term edge in operational efficiency.
2734.24%
Net income/share CAGR above 1.5x NEM's 1135.83% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
292.06%
Positive 5Y CAGR while NEM is negative. John Neff might view this as a strong mid-term relative advantage.
215.81%
Positive short-term CAGR while NEM is negative. John Neff would see a clear advantage in near-term profit trajectory.
3071.55%
10Y equity/share CAGR above 1.5x NEM's 101.08%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
146.06%
5Y equity/share CAGR above 1.5x NEM's 59.53%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.98%
3Y equity/share CAGR above 1.5x NEM's 32.96%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.09%
AR growth well above NEM's 36.28%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-0.34%
Negative asset growth while NEM invests at 3.01%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.54%
1.25-1.5x NEM's 3.30%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-11.10%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-8.05%
We cut SG&A while NEM invests at 23.29%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.